XML 14 R2.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended
Jan. 03, 2025
Dec. 29, 2023
Income Statement [Abstract]    
Revenues, net $ 199.8 $ 190.0
Cost of revenues 131.3 132.9
Gross profit 68.5 57.1
Operating expenses:    
Research and development 23.5 20.5
Selling, general, and administrative 33.8 32.4
Total operating expenses 57.3 52.9
Operating income 11.2 4.2
Interest income 2.1 1.9
Interest expense (8.0) (7.3)
Other (expense) income, net (2.8) 0.6
Interest and other expense, net (8.7) (4.8)
Income (loss) before taxes 2.5 (0.6)
Income tax expense (benefit) 2.6 (0.2)
Net loss (0.1) (0.4)
Less: Net income attributable to noncontrolling interests 0.2 0.1
Net loss attributable to Varex $ (0.3) $ (0.5)
Net loss per common share attributable to Varex    
Basic (in USD per share) $ (0.01) $ (0.01)
Diluted (in USD per share) $ (0.01) $ (0.01)
Weighted average common shares outstanding    
Basic (in shares) 41.1 40.6
Diluted (in shares) 41.1 40.6